Novel High‐Resolution Lipidomes Could Serve as New Biomarkers for Diabetic Retinopathy: A Bidirectional and Mediated Mendelian Randomization Study
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70614 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yuxin Sun und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Mendelian Randomization Analysis, Biomarkers, Lipidomics. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: President's Fund of Zhujiang Hospital of Southern Medical University, Administration of Traditional Chinese Medicine of Guangdong Province.
Abstract (Originalsprache)
Although lipid metabolism is a critical factor in the pathogenesis of diabetic retinopathy (DR), the connection between lipidome and DR is still a subject of debate. We aimed to demonstrate that lipidome could serve as novel biomarkers for DR and elucidate the mediating role of inflammatory factors. Data for our investigation are available from the GWAS catalogue and FinnGen Biobank. The bidirectional Mendelian randomization (MR) analyses were conducted to assess the “total effect” between lipidome and DR and its subtypes. Subsequently, the mediation analyses were performed to explore the involvement of circulating inflammatory proteins in mediating the connection between them. Mediation proportion was calculated to measure the contribution of inflammatory factors to the overall effect. Ultimately, a battery of sensitivity tests proceeded to examine the dependability of the findings. This study has revealed a causal relationship between lipidome and different stages of DR. Additionally, we have successfully discovered a range of new lipids that protect against DR and have the potential to serve as new markers. This study also highlights the important role of inflammatory factors in elucidating the protective mechanisms of lipids against DR and provides new perspectives on lipidomic‐based treatments and cytokine‐targeted interventions for DR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
- Ophthalmology Department, Zhujiang Hospital Affiliated With Southern Medical University, Guangzhou, China.
- Department of Ophthalmology, the Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, China.
- Department of Ophthalmology, the Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Biomedical Innovation Center, the Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Center for Teaching and Learning Development, Southern Medical University, Guangzhou, China.
ORCID-Profile: Zejun Chen, Min Fu
Förderung
- President's Fund of Zhujiang Hospital of Southern Medical University
- Administration of Traditional Chinese Medicine of Guangdong Province
Zitieren
APA
Sun, Y., Zhang, Z., Chen, Z., Li, Z., Wang, Z., Wu, F., Ma, X., Wang, S., Cao, M., Yi, G., & Fu, M. (2025). Novel High‐Resolution Lipidomes Could Serve as New Biomarkers for Diabetic Retinopathy: A Bidirectional and Mediated Mendelian Randomization Study. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70614
Vancouver
Sun Y, Zhang Z, Chen Z, Li Z, Wang Z, Wu F, et al. Novel High‐Resolution Lipidomes Could Serve as New Biomarkers for Diabetic Retinopathy: A Bidirectional and Mediated Mendelian Randomization Study. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70614
BibTeX
@article{Sun2025,
author = {Sun, Yuxin and Zhang, Ziran and Chen, Zejun and Li, Zhengran and Wang, Zijin and Wu, Fanye and Ma, Xinyu and Wang, Shaoyu and Cao, Mingzhe and Yi, Guoguo and Fu, Min},
title = {Novel High‐Resolution Lipidomes Could Serve as New Biomarkers for Diabetic Retinopathy: A Bidirectional and Mediated Mendelian Randomization Study},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70614}
}
EUVIMED